Neuland Laboratories Limited (BOM:524558)

Neuland Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	275,795	154,121	154,946	80,588	23,087	13,171
Market Cap Growth	47.02%	-0.53%	92.27%	249.07%	75.28%	-50.83%
Enterprise Value	278,041	155,079	154,137	80,232	24,941	15,076
Last Close Price	21496.30	11990.49	12044.69	6253.69	1785.37	1014.28

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	55.40	42.34	59.57	26.86	14.12	20.64
Forward PE	63.68	39.04	44.12	25.58	20.20	15.19
PS Ratio	11.63	7.62	10.49	5.17	1.94	1.38
PB Ratio	14.71	8.22	10.16	6.28	2.32	1.57
P/TBV Ratio	17.36	9.70	12.49	8.05	3.24	2.36
P/FCF Ratio	-	-	139.67	68.58	13.49	-
P/OCF Ratio	79.55	44.46	48.82	30.86	9.73	21.81
PEG Ratio	-	0.87	0.68	0.68	0.68	0.68

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	11.72	7.67	10.44	5.15	2.09	1.58
EV/EBITDA Ratio	36.36	27.33	47.53	17.49	8.93	10.74
EV/EBIT Ratio	41.49	31.78	58.16	19.89	10.82	15.69
EV/FCF Ratio	-	-	138.94	68.28	14.58	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.16	0.16	0.10	0.07	0.13	0.29
Debt / EBITDA Ratio	0.39	0.52	0.48	0.21	0.46	1.67
Debt / FCF Ratio	-	-	1.42	0.81	0.75	-
Net Debt / Equity Ratio	0.12	0.12	-0.05	0.01	0.08	0.28
Net Debt / EBITDA Ratio	0.30	0.40	-0.25	0.02	0.30	1.65
Net Debt / FCF Ratio	-	-4.45	-0.74	0.07	0.49	-6.22
Asset Turnover	-	0.79	0.74	0.91	0.80	0.70
Inventory Turnover	-	2.11	2.04	2.33	2.26	2.16
Quick Ratio	-	0.89	1.21	1.10	0.95	0.69
Current Ratio	-	2.09	2.45	2.15	1.73	1.60
Return on Equity (ROE)	-	21.42%	18.53%	26.36%	17.83%	7.85%
Return on Assets (ROA)	-	11.94%	8.26%	14.77%	9.73%	4.44%
Return on Invested Capital (ROIC)	23.74%	20.52%	14.57%	25.47%	16.26%	7.34%
Return on Capital Employed (ROCE)	-	22.00%	15.50%	28.70%	20.20%	9.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.80%	2.36%	1.68%	3.72%	7.08%	4.85%
FCF Yield	-0.18%	-0.33%	0.72%	1.46%	7.41%	-2.83%
Dividend Yield	0.16%	0.28%	0.10%	0.22%	0.56%	0.49%
Payout Ratio	-	4.23%	6.91%	4.28%	3.92%	6.03%
Total Shareholder Return	0.18%	0.28%	0.10%	0.22%	0.56%	0.49%

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 1, 2026

Data Sources Report a data error